Silencing of HMGA2 by siRNA loaded methotrexate functionalized polyamidoamine dendrimer for human breast cancer cell therapy

F Abedi Gaballu, WCS Cho, G Dehghan, A Zarebkohan… - Genes, 2021 - mdpi.com
The transcription factor high mobility group protein A2 (HMGA2) plays an important role in
the pathogenesis of some cancers including breast cancer. Polyamidoamine dendrimer …

Glutaryl polyamidoamine dendrimer for overcoming cisplatin-resistance of breast cancer cells

X Xu, Y Li, X Lu, Y Sun, J Luo… - Journal of Nanoscience …, 2018 - ingentaconnect.com
Objective: Cisplatin has limited clinical applications due to drug resistance. PAMAM
dendrimer was chosen as a vehicle to counteract cisplatin-resistance and its mechanism …

Effective Role of Polyamidoamine (PAMAM) Dendrimer functionalized nanomaterials in anticancer applications

S Nandhabala, J Hemalatha, C Senthamil… - …, 2023 - Wiley Online Library
One of the most severe health diseases affect the mankind is cancer. The treatment methods
such as magnetic hyperthermia, chemotherapy, photothermal therapy and MRI‐traced …

Molecular mechanisms of antitumor activity of PAMAM dendrimer conjugates with anticancer drugs and a monoclonal antibody

M Marcinkowska, M Stanczyk, A Janaszewska, A Gajek… - Polymers, 2019 - mdpi.com
Taxanes are considered fundamental drugs in the treatment of breast cancer, but despite the
similarities, docetaxel (doc) and paclitaxel (ptx) work differently. For this reason, it is …

Partial surface modification of low generation polyamidoamine dendrimers: Gaining insight into their potential for improved carboplatin delivery

DH Nguyen, LG Bach, DH Nguyen Tran, VD Cao… - Biomolecules, 2019 - mdpi.com
Carboplatin (CAR) is a second generation platinum-based compound emerging as one of
the most widely used anticancer drugs to treat a variety of tumors. In an attempt to address …

[HTML][HTML] Lapatinib-and fulvestrant-PAMAM dendrimer conjugates promote apoptosis in chemotherapy-induced senescent breast cancer cells with different receptor …

A Lewińska, K Wróbel, D Błoniarz… - Biomaterials …, 2022 - Elsevier
Lapatinib (L) and fulvestrant (F) are used in targeted anticancer therapies, in particular,
against phenotypically different breast cancer cells. L, a dual inhibitor of EGFR and HER2 …

The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells

J Zhang, D Liu, M Zhang, Y Sun, X Zhang… - International journal …, 2016 - Taylor & Francis
Polyamidoamine dendrimers, which can deliver drugs and genetic materials to resistant
cells, are attracting increased research attention, but their transportation behavior in …

Modified carboxyl-terminated PAMAM dendrimers as great cytocompatible nano-based drug delivery system

MT Vu, LG Bach, DC Nguyen, MN Ho… - International Journal of …, 2019 - mdpi.com
Polyamidoamine (PAMAM) dendrimers are extensively researched as potential drug
delivery system thanks to their desirable features such as controlled and stable structures …

Zerumbone‐Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells

JN Foong, GT Selvarajah, A Rasedee… - BioMed research …, 2018 - Wiley Online Library
Canine mammary gland tumor (CMT) is the most common tumor in intact female dog.
Zerumbone (ZER) has promising anticancer properties, but plagued with poor water …

Chemical characterization (LC–MS–ESI), cytotoxic activity and intracellular localization of PAMAM G4 in leukemia cells

R Flores-Mejía, MJ Fragoso-Vázquez… - Scientific Reports, 2021 - nature.com
Generation 4 of polyamidoamine dendrimer (G4-PAMAM) has several biological effects due
to its tridimensional globular structure, repetitive branched amides, tertiary amines, and …